Skip to content

Video Tutorial

Antibodies and Antibody-Drug Conjugate Higher Order Structures Revealed

In this tutorial, you will find:

  • Characterization of mAb’s and ADC’s without the need for dilutions or concern for your formulation buffer’s excipient interferences, enabled by MMS, is critical to understand the TRUE structure of your drug product at the intended therapeutic conditions.
  • Microfluidic Modulation Spectroscopy provides a reliable platform with increased sensitive and higher resolution for secondary structure analysis of biotherapeutics.
  • MMS’s Automated walk away workflow makes it applicable for screening studies much earlier in the development process.

Speakers

Shah_Karan_051018_Immunogen

Karan K. Shah

Papayannopoulos_photo

Ioannis Papayannopoulos

eugene-ma

Eugene Ma

Tutorial brought to you by

REDSHIFTbio_TM_tag

[RedShiftBio] Webinar Dec 12 2018 Antibodies and Antibody-Drug

A Guide to Harnessing DNA Assembly for Drug Discovery

  • Subscribe and get access to this premium video tutorial

  • ​​All emails include an unsubscribe link. You may opt-out at any time. See our Privacy Policy & Terms & Conditions
  • This field is for validation purposes and should be left unchanged.

All Bitesize Bio emails contain an unsubscribe link.
You can review our privacy policy, cookie policy and terms and conditions online.

Tutorial abstract

Recently investigators have begun to harness new technology such as microfluidic modulation spectroscopy (MMS) to reveal protein structural changes, as a solid understanding of structure and function is extremely important to the effectiveness of biotherapeutic drugs and scientist today are challenged in gathering a complete understanding with current tools During the biomanufacturing process, proteins such as antibodies, often undergo conformational changes that can alter their secondary structure, leading to critical variations in their overall function. These changes have been historically difficult to detect, as traditional analytical techniques are not great at detecting small differences in protein structure. MMS however, can detect these changes with great sensitivity and accuracy without the need for dilution or chemical alteration. Moreover, MMS offers detailed information on which structural motifs in the protein molecule are changing, providing more guidance to scientists in their efforts to develop more stable antibody molecules and formulations. Join us for this new BitesizeBio webinar where we will learn how MMS technology is making a significant impact toward understanding the structures of therapeutic antibodies and antibody drug conjugates.

Learning Objectives:

  • How Microfluidic Modulation Spectroscopy (MMS) can be used to understand the structures of therapeutic antibodies and antibody drug conjugates
  • Introduction to the AQS3™pro MMS system from RedShiftBio
Subscribe To Watch This Tutorial
Share this to your network:
LinkedIn
Scroll To Top